Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

GSTP1 positive prostatic adenocarcinomas are more common in Black than White men in the United States

Igor Vidal, Qizhi Zheng, Jessica L. Hicks, View ORCID ProfileJiayu Chen, View ORCID ProfileElizabeth A. Platz, Bruce J. Trock, View ORCID ProfileIbrahim Kulac, View ORCID ProfileJavier A. Baena-Del Valle, View ORCID ProfileKaren S. Sfanos, View ORCID ProfileSarah Ernst, Tracy Jones, View ORCID ProfileStephanie Glavaris, View ORCID ProfileWilliam G. Nelson, View ORCID ProfileSrinivasan Yegnasubramanian, View ORCID ProfileAngelo Michael De Marzo
doi: https://doi.org/10.1101/2020.08.28.20183954
Igor Vidal
1 The Johns Hopkins University School of Medicine;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: igordamascenovidal@gmail.com
Qizhi Zheng
1 The Johns Hopkins University School of Medicine;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: qzheng3@jhmi.edu
Jessica L. Hicks
1 The Johns Hopkins University School of Medicine;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: jbeckman@jhmi.edu
Jiayu Chen
1 The Johns Hopkins University School of Medicine;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jiayu Chen
  • For correspondence: jchen248@jhmi.edu
Elizabeth A. Platz
1 The Johns Hopkins University School of Medicine;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Elizabeth A. Platz
  • For correspondence: eplatz1@jhu.edu
Bruce J. Trock
1 The Johns Hopkins University School of Medicine;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: btrock313@gmail.com
Ibrahim Kulac
2 Koc University, Istanbul, Turkey;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ibrahim Kulac
  • For correspondence: ikulac@ku.edu.tr
Javier A. Baena-Del Valle
3 Fundación Santa Fe de Bogotá University Hospital, Bogotá, Colombia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Javier A. Baena-Del Valle
  • For correspondence: jbaenad@hotmail.com
Karen S. Sfanos
1 The Johns Hopkins University School of Medicine;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Karen S. Sfanos
  • For correspondence: ksfanos@jhmi.edu
Sarah Ernst
1 The Johns Hopkins University School of Medicine;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sarah Ernst
  • For correspondence: sgalinn1@jhmi.edu
Tracy Jones
1 The Johns Hopkins University School of Medicine;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: tjone166@jhmi.edu
Stephanie Glavaris
1 The Johns Hopkins University School of Medicine;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Stephanie Glavaris
  • For correspondence: sglavar1@jhmi.edu
William G. Nelson
1 The Johns Hopkins University School of Medicine;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for William G. Nelson
  • For correspondence: bnelson@jhmi.edu
Srinivasan Yegnasubramanian
1 The Johns Hopkins University School of Medicine;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Srinivasan Yegnasubramanian
  • For correspondence: syegnasu@jhmi.edu
Angelo Michael De Marzo
1 The Johns Hopkins University School of Medicine;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Angelo Michael De Marzo
  • For correspondence: ademarz@jhmi.edu
  • Abstract
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

GSTP1 is a member of the Glutathione-S-transferase (GSTS) family silenced by CpG island DNA hypermethylation in 90-95% of prostate cancers. However, prostate cancers expressing GSTP1 have not been well characterized. We used immunohistochemistry against GSTP1 to examine 1673 primary prostatic adenocarcinomas on TMAs with redundant sampling from the index tumor from prostatectomies. GSTP1 protein was positive in at least one TMA core in 7.7% of cases and in all TMA cores in 4.4% of cases. The percentage of adenocarcinomas from Black patients who had any GSTP1 positive TMA cores was 14.9%, which was 2.5 times higher than the percentage from White patients (5.9%; P < 0.001). Further, the percentages of tumors from Black patients who had all TMA spots positive for GSTP1 (9.5%) was 3-fold higher than the percentage from White patients (3.2%; P<0.001). The increased percentage of GSTP1 positive cases in Black men was present only in ERG positive cases. By in situ hybridization, GSTP1 mRNA expression was concordant with protein staining, supporting the lack of silencing of at least some GSTP1 alleles in GSTP1-positive tumor cells. This is the first report revealing that the GSTP1-positive prostate cancer subset is substantially over-represented among prostate cancers from Black compared to White men. This observation should prompt additional studies to determine whether GSTP1 positive cases represent a distinct molecular subtype of prostate cancer and whether GSTP1 expression could provide a biological underpinning for the observed disparate outcomes for Black men.

Competing Interest Statement

pending

Funding Statement

Supported by U.S. NIH/NCI SPORE in Prostate Cancer: P50CA58236, and the U.S. NIH/NCI U01 CA196390 for the Molecular and Cellular Characterization of Screen Detected Lesions (MCL), the U.S. Department of Defense Prostate Cancer Research Program (PCRP): W81XWH-18-2-0015. The Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Oncology Tissue Services Laboratory supported by NIH/NCI grant P30 CA006973.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The Johns Hopkins University School of Medicine

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

not applicable

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted September 01, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
GSTP1 positive prostatic adenocarcinomas are more common in Black than White men in the United States
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
GSTP1 positive prostatic adenocarcinomas are more common in Black than White men in the United States
Igor Vidal, Qizhi Zheng, Jessica L. Hicks, Jiayu Chen, Elizabeth A. Platz, Bruce J. Trock, Ibrahim Kulac, Javier A. Baena-Del Valle, Karen S. Sfanos, Sarah Ernst, Tracy Jones, Stephanie Glavaris, William G. Nelson, Srinivasan Yegnasubramanian, Angelo Michael De Marzo
medRxiv 2020.08.28.20183954; doi: https://doi.org/10.1101/2020.08.28.20183954
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
GSTP1 positive prostatic adenocarcinomas are more common in Black than White men in the United States
Igor Vidal, Qizhi Zheng, Jessica L. Hicks, Jiayu Chen, Elizabeth A. Platz, Bruce J. Trock, Ibrahim Kulac, Javier A. Baena-Del Valle, Karen S. Sfanos, Sarah Ernst, Tracy Jones, Stephanie Glavaris, William G. Nelson, Srinivasan Yegnasubramanian, Angelo Michael De Marzo
medRxiv 2020.08.28.20183954; doi: https://doi.org/10.1101/2020.08.28.20183954

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Pathology
Subject Areas
All Articles
  • Addiction Medicine (62)
  • Allergy and Immunology (142)
  • Anesthesia (44)
  • Cardiovascular Medicine (408)
  • Dentistry and Oral Medicine (67)
  • Dermatology (47)
  • Emergency Medicine (141)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (171)
  • Epidemiology (4810)
  • Forensic Medicine (3)
  • Gastroenterology (177)
  • Genetic and Genomic Medicine (671)
  • Geriatric Medicine (70)
  • Health Economics (187)
  • Health Informatics (621)
  • Health Policy (314)
  • Health Systems and Quality Improvement (200)
  • Hematology (85)
  • HIV/AIDS (155)
  • Infectious Diseases (except HIV/AIDS) (5280)
  • Intensive Care and Critical Care Medicine (326)
  • Medical Education (91)
  • Medical Ethics (24)
  • Nephrology (73)
  • Neurology (677)
  • Nursing (41)
  • Nutrition (110)
  • Obstetrics and Gynecology (124)
  • Occupational and Environmental Health (203)
  • Oncology (438)
  • Ophthalmology (138)
  • Orthopedics (36)
  • Otolaryngology (88)
  • Pain Medicine (35)
  • Palliative Medicine (15)
  • Pathology (127)
  • Pediatrics (193)
  • Pharmacology and Therapeutics (129)
  • Primary Care Research (84)
  • Psychiatry and Clinical Psychology (768)
  • Public and Global Health (1798)
  • Radiology and Imaging (321)
  • Rehabilitation Medicine and Physical Therapy (138)
  • Respiratory Medicine (255)
  • Rheumatology (86)
  • Sexual and Reproductive Health (68)
  • Sports Medicine (61)
  • Surgery (100)
  • Toxicology (23)
  • Transplantation (28)
  • Urology (37)